Genentech Posts Higher Earnings
Genentech (DNA ) posted 29 cents, vs. 19 cents first-quarter earnings per share on 50% higher operating revenue and 55% higher total product sales. The company posts Avastin U.S. sales of $675.9 million, which is below some Street estimates. It expects 2005 earnings per share growth of greater than 30%.
FLIR Systems (FLIR ) shares dropped Tuesday after the company said it sees first quarter EPS of 18 cents to 20 cents on revenue of about $108 million. FLIR cited a slowdown in its Imaging business. JP Morgan and Thomas Weisel cut estimates.
Travelzoo (TZOO ) shares dropped after the company posted lower-than-expected firsat quarter EPS of 10 cents, vs. 5 cents, on a 74% revenue rise. Legg Mason reiterates sell.
Citigroup upgraded TiVo (TIVO ) to buy from hold. The shares moved higher Tuesday. The company was unavailable for comment.
BMC Software (BMC ) sees lower-than-expected fourth-quarter revenue of $388 million to $400 million, and earnings per share of 8 cents to 12 cents. The company sets a restructuring plan, which includes a staff reduction of about 12% of the total workforce. S&P maintains hold.
SpectraLink (SLNK ) sees lower-than-expected first-quarter revenue of about $20.6 million due to unexpected weakness in OEM and major reseller channels. The company sees about 11 cents earnings per share, in line with plans due to higher-than-expected gross margins and cost controls.
Abbott Laboratories (ABT ) posted 53 cents, vs. 52 cents first-quarter earnings per share on a 16% sales rise. The company sees 56 cents to 58 cents second-quarter operating earnings per share. The company maintains $2.47 to $2.53 2005 earnings per share guidance, excluding one-time charges and the effect of new accounting rules to expense stock options.
The U.S. Consumer Product Safety Commission announced Nautilus (NLS ) is to pay a $950,000 civil penalty to settle allegations that it failed to give CPSC timely reports on serious injuries and safety defects with Bowflex fitness machines.
Carrier Access (CACS ) sees first-quarter revenue of $12.3 million to $12.5 million. The company sets a 5 million share buyback. Janney Montgomery reportedly downgrades to neutral from buy.
Celgene (CELG ) reports North American and International Multiple Myeloma Phase III trials confirm significant clinical benefit for patients treated with Revlimid plus dexamethasone.
Due to continuing strong sales, Black & Decker (BDK ) sees 15% first-quarter sales growth, excluding foreign exchange and acquisitions. The company raises $1.05 to $1.10 first-quarter earnings per share (continuing operations) forecast to $1.33 to $1.35. It is comfortable with $1.67 analysts' second-quarter mean earnings per share estimate.
Ameritrade (AMTD ) posted 17 cents, vs. 19 cents second-quarter earnings per share on a 5.8% net revenue drop. The company notes a slowdown in trading activity. It tightens its fiscal 2005 earnings per share forecast range to 77 cents to 87 cents.
Dusa Pharmaceuticals (DUSA ) announces end-users Kerastick sales to physicians totaled 28,704 in the first-quarter, up 107% in the U.S. and up 138% overall, vs. fiscal 2004.
BioSource International (BIOI ) board unanimously rejects an unsolicited proposal from Bio-Rad Labs to acquire all of BioSource's outstanding shares at $8.50 per share cash.
Noland (NOLD ) agrees to be acquired by WinWholesale. Terms of the agreement give $74 cash for each Noland share.